A few thoughtsRVX/Zenith Management One of the things that has been bothering me is what kind of company did I invest in? I hadn't paid attention since I put money in 5 years ago. Because of the slow progress I was beginning to think perhaps I had invested in some wild west company.
Well,
I think I proved that hypothesis completely wrong. I read the bios of the board members, management team and each advisory board's members and as you all probably know it is very impressive.
- There is an incredible depth of scientific and pharma experience.
- In terms of scientiific profile some of these people have published many research papers and thus probably have high recognition and respect.
- A number of these people have held business development positions across various companies.
- The experience and reach across pharma companies is very significant.
This seems like a remarkable team of great intellectual strength and also connections in the pharma industry. It certainly reassures me of the talent, dedication and integrity of their human resources.
So I don't think the issues reside with the science, lack of integrity or lack of intellectual strength. I feel very assured.
Post hoc analysis of rvx-208 is very positive. How can this be packed in a deal and leveraged with the wider retail shareholder market (who should be recognized as important to Resverlogix).
Zenith IPO Sanfran, I understand your POV regarding the Zenith IPO being done after the Resverlogix deal is done. I'm fine with that as long the the Resverlogix deal is done before mid April, and I, like most, am completely in the dark about the status of RVX...but hopeful.
I know I am becoming redundant regarding the Zenith IPO but I'll express my thoughts one more time.
- It's been 10 months since Zenith was split out from RVX.
- There would have been 8 to 12 months of planning this before the filing (i.e. management has had a long time to think about this).
- I believe that in the structuring of the spin off Zenith was provided a significant amount of funding ($3MM+) that would be one of the criteria required for a listing.
- I also remember that the structure of the financial data would fit the requirements for a listing.
- The website for Zenith was launched in September 2013.
- Parallel to that should have been the structuring of the information required for a listing on the TSX and NASDAQ.
- And parallel to that should have been a complete PR plan to leverage the IPO.
So my bottom line is that I'd like to see the IPO in April 2014 particularly given that there were no concrete plans presented in February.
I respect the fact that the company must keep confidentiality on deals they are working on but the structuring, which I favoured, that happened last spring gave every suggestion of an IPO.
Anyway, some thoughts.
Cheers
Toinv